Abeona therapeutics further strengthens board with appointment of two new independent directors

New york and cleveland, june 17, 2020 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced board of director appointments that strengthen and expand the company’s leadership. george migausky and paul mann were appointed as independent directors, effective june 17, 2020. in addition to their board service, mr. migausky will serve as chairman of the company's audit committee and mr. mann will serve as a member of the audit committee.
ABEO Ratings Summary
ABEO Quant Ranking